Chemotherapy and Immunotherapy in Urologic Oncology: A Guide for the Advanced Practice Provider
This book is designed to familiarize clinical practitioners in systemic therapy options and medical management of urologic malignancies including prostate cancer, bladder and upper tract urothelial carcinoma, and renal cell carcinoma. Organized by organ system, the text highlights new therapies such...
Gespeichert in:
| Weitere Verfasser: | , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Cham
Springer International Publishing
2021
|
| Ausgabe: | 1st edition |
| Schlagworte: | |
| Online-Zugang: | UBR01 Volltext |
| Zusammenfassung: | This book is designed to familiarize clinical practitioners in systemic therapy options and medical management of urologic malignancies including prostate cancer, bladder and upper tract urothelial carcinoma, and renal cell carcinoma. Organized by organ system, the text highlights new therapies such as novel forms of androgen deprivation, cytotoxic chemotherapy, immune check point and immunomodulatory agents, and targeted therapies. Written by experts in the field, the book also reviews current chemotherapy and immunotherapy regimens for genitourinary malignancies and discusses indications, outcomes, and toxicities, as well as clinical trial concepts. Each of the book's chapters offers a bulleted box of clinical pearls on the particular role of the APP. Chemotherapy and Immunotherapy in Urologic Oncology: A Guide for the Advanced Practice Provider is a resource for urologists, uro-radiologists, medical clinicians and family practitioners alike, familiarizing its audiences with systemic therapy regimens for urologic malignancies, as well as their expected outcomes and side effects. |
| Beschreibung: | Introduction: Integration of APP into Urologic Oncology Practice -- Overview and Active Surveillance of Prostate Cancer -- Monitoring and Managing Men Following Initial Treatment of Prostate Cancer -- Radical Prostatectomy and Survivorship after Radical Prostatectomy -- Multimodal Treatment Plans in Prostate Cancer -- Radiotherapy for Prostate Cancer -- Androgen Deprivation Treatment -- Second Generation Androgen Targeted Agents -- Chemotherapy and prostate cancer -- Radiopharmaceuticals for Prostate Cancer -- Immunotherapy and Novel Agents on the Horizon for the Treatment of Prostate Cancer -- Bladder Cancer -- Intravesical Therapy for Non Muscle Invasive Urothelial Carcinoma -- Bladder Cancer: Muscle Invasive Disease -- Chemoradiation Bladder Preservation -- Metastatic Bladder Cancer and the Use of Cisplatin Chemotherapy -- Immunotherapy for Metastatic Urothelial Cancer -- Novel and experimental Strategies in the treatment of Metastatic Urothelial Carcinoma -- Upper Tract Urothelial Carcinoma -- Kidney Cancer and Its Treatment -- Targeted Therapies for Treatment of Metastatic Renal Cell Carcinoma -- Immune Therapies for Metastatic Kidney Cancer -- Novel Therapies for Renal Cell Carcinoma -- Testicular Cancer -- Penile Cancer |
| Beschreibung: | 1 Online-Ressource (XIV, 307 Seiten) Illustrationen |
| ISBN: | 9783030520212 |
| DOI: | 10.1007/978-3-030-52021-2 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV046997435 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 201113s2021 |||| o||u| ||||||eng d | ||
| 020 | |a 9783030520212 |9 978-3-030-52021-2 | ||
| 024 | 7 | |a 10.1007/978-3-030-52021-2 |2 doi | |
| 035 | |a (ZDB-2-SME)978-3-030-52021-2 | ||
| 035 | |a (OCoLC)1220904377 | ||
| 035 | |a (DE-599)BVBBV046997435 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-578 | ||
| 082 | 0 | |a 616.6 | |
| 245 | 1 | 0 | |a Chemotherapy and Immunotherapy in Urologic Oncology |b A Guide for the Advanced Practice Provider |c edited by Edouard J. Trabulsi, Costas D. Lallas, Anne E. Lizardi-Calvaresi |
| 250 | |a 1st edition | ||
| 264 | 1 | |a Cham |b Springer International Publishing |c 2021 | |
| 300 | |a 1 Online-Ressource (XIV, 307 Seiten) |b Illustrationen | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Introduction: Integration of APP into Urologic Oncology Practice -- Overview and Active Surveillance of Prostate Cancer -- Monitoring and Managing Men Following Initial Treatment of Prostate Cancer -- Radical Prostatectomy and Survivorship after Radical Prostatectomy -- Multimodal Treatment Plans in Prostate Cancer -- Radiotherapy for Prostate Cancer -- Androgen Deprivation Treatment -- Second Generation Androgen Targeted Agents -- Chemotherapy and prostate cancer -- Radiopharmaceuticals for Prostate Cancer -- Immunotherapy and Novel Agents on the Horizon for the Treatment of Prostate Cancer -- Bladder Cancer -- Intravesical Therapy for Non Muscle Invasive Urothelial Carcinoma -- Bladder Cancer: Muscle Invasive Disease -- Chemoradiation Bladder Preservation -- Metastatic Bladder Cancer and the Use of Cisplatin Chemotherapy -- Immunotherapy for Metastatic Urothelial Cancer -- Novel and experimental Strategies in the treatment of Metastatic Urothelial Carcinoma -- Upper Tract Urothelial Carcinoma -- Kidney Cancer and Its Treatment -- Targeted Therapies for Treatment of Metastatic Renal Cell Carcinoma -- Immune Therapies for Metastatic Kidney Cancer -- Novel Therapies for Renal Cell Carcinoma -- Testicular Cancer -- Penile Cancer | ||
| 520 | |a This book is designed to familiarize clinical practitioners in systemic therapy options and medical management of urologic malignancies including prostate cancer, bladder and upper tract urothelial carcinoma, and renal cell carcinoma. Organized by organ system, the text highlights new therapies such as novel forms of androgen deprivation, cytotoxic chemotherapy, immune check point and immunomodulatory agents, and targeted therapies. Written by experts in the field, the book also reviews current chemotherapy and immunotherapy regimens for genitourinary malignancies and discusses indications, outcomes, and toxicities, as well as clinical trial concepts. Each of the book's chapters offers a bulleted box of clinical pearls on the particular role of the APP. Chemotherapy and Immunotherapy in Urologic Oncology: A Guide for the Advanced Practice Provider is a resource for urologists, uro-radiologists, medical clinicians and family practitioners alike, familiarizing its audiences with systemic therapy regimens for urologic malignancies, as well as their expected outcomes and side effects. | ||
| 650 | 4 | |a Urology | |
| 650 | 4 | |a Oncology | |
| 650 | 4 | |a General practice (Medicine) | |
| 650 | 4 | |a Primary care (Medicine) | |
| 700 | 1 | |a Trabulsi, Edouard J. |4 edt | |
| 700 | 1 | |a Lallas, Costas D. |4 edt | |
| 700 | 1 | |a Lizardi-Calvaresi, Anne E. |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783030520205 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783030520229 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-030-52021-2 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SME |a ZDB-2-SXM | ||
| 940 | 1 | |q ZDB-2-SME_2021_Fremddaten | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-032405161 | ||
| 966 | e | |u https://doi.org/10.1007/978-3-030-52021-2 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_2021_Fremddaten |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804181943947886592 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author2 | Trabulsi, Edouard J. Lallas, Costas D. Lizardi-Calvaresi, Anne E. |
| author2_role | edt edt edt |
| author2_variant | e j t ej ejt c d l cd cdl a e l c ael aelc |
| author_facet | Trabulsi, Edouard J. Lallas, Costas D. Lizardi-Calvaresi, Anne E. |
| building | Verbundindex |
| bvnumber | BV046997435 |
| collection | ZDB-2-SME ZDB-2-SXM |
| ctrlnum | (ZDB-2-SME)978-3-030-52021-2 (OCoLC)1220904377 (DE-599)BVBBV046997435 |
| dewey-full | 616.6 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.6 |
| dewey-search | 616.6 |
| dewey-sort | 3616.6 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| discipline_str_mv | Medizin |
| doi_str_mv | 10.1007/978-3-030-52021-2 |
| edition | 1st edition |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04069nmm a2200469zc 4500</leader><controlfield tag="001">BV046997435</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">201113s2021 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783030520212</subfield><subfield code="9">978-3-030-52021-2</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-030-52021-2</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-3-030-52021-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1220904377</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046997435</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.6</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Chemotherapy and Immunotherapy in Urologic Oncology</subfield><subfield code="b">A Guide for the Advanced Practice Provider</subfield><subfield code="c">edited by Edouard J. Trabulsi, Costas D. Lallas, Anne E. Lizardi-Calvaresi</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st edition</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cham</subfield><subfield code="b">Springer International Publishing</subfield><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XIV, 307 Seiten)</subfield><subfield code="b">Illustrationen</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Introduction: Integration of APP into Urologic Oncology Practice -- Overview and Active Surveillance of Prostate Cancer -- Monitoring and Managing Men Following Initial Treatment of Prostate Cancer -- Radical Prostatectomy and Survivorship after Radical Prostatectomy -- Multimodal Treatment Plans in Prostate Cancer -- Radiotherapy for Prostate Cancer -- Androgen Deprivation Treatment -- Second Generation Androgen Targeted Agents -- Chemotherapy and prostate cancer -- Radiopharmaceuticals for Prostate Cancer -- Immunotherapy and Novel Agents on the Horizon for the Treatment of Prostate Cancer -- Bladder Cancer -- Intravesical Therapy for Non Muscle Invasive Urothelial Carcinoma -- Bladder Cancer: Muscle Invasive Disease -- Chemoradiation Bladder Preservation -- Metastatic Bladder Cancer and the Use of Cisplatin Chemotherapy -- Immunotherapy for Metastatic Urothelial Cancer -- Novel and experimental Strategies in the treatment of Metastatic Urothelial Carcinoma -- Upper Tract Urothelial Carcinoma -- Kidney Cancer and Its Treatment -- Targeted Therapies for Treatment of Metastatic Renal Cell Carcinoma -- Immune Therapies for Metastatic Kidney Cancer -- Novel Therapies for Renal Cell Carcinoma -- Testicular Cancer -- Penile Cancer</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This book is designed to familiarize clinical practitioners in systemic therapy options and medical management of urologic malignancies including prostate cancer, bladder and upper tract urothelial carcinoma, and renal cell carcinoma. Organized by organ system, the text highlights new therapies such as novel forms of androgen deprivation, cytotoxic chemotherapy, immune check point and immunomodulatory agents, and targeted therapies. Written by experts in the field, the book also reviews current chemotherapy and immunotherapy regimens for genitourinary malignancies and discusses indications, outcomes, and toxicities, as well as clinical trial concepts. Each of the book's chapters offers a bulleted box of clinical pearls on the particular role of the APP. Chemotherapy and Immunotherapy in Urologic Oncology: A Guide for the Advanced Practice Provider is a resource for urologists, uro-radiologists, medical clinicians and family practitioners alike, familiarizing its audiences with systemic therapy regimens for urologic malignancies, as well as their expected outcomes and side effects.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Urology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology </subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">General practice (Medicine)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Primary care (Medicine)</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Trabulsi, Edouard J.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lallas, Costas D.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lizardi-Calvaresi, Anne E.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783030520205</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783030520229</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-3-030-52021-2</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield><subfield code="a">ZDB-2-SXM</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_2021_Fremddaten</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-032405161</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-030-52021-2</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_2021_Fremddaten</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV046997435 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T15:55:36Z |
| indexdate | 2024-07-10T08:59:42Z |
| institution | BVB |
| isbn | 9783030520212 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-032405161 |
| oclc_num | 1220904377 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-578 |
| owner_facet | DE-355 DE-BY-UBR DE-578 |
| physical | 1 Online-Ressource (XIV, 307 Seiten) Illustrationen |
| psigel | ZDB-2-SME ZDB-2-SXM ZDB-2-SME_2021_Fremddaten ZDB-2-SME ZDB-2-SME_2021_Fremddaten |
| publishDate | 2021 |
| publishDateSearch | 2021 |
| publishDateSort | 2021 |
| publisher | Springer International Publishing |
| record_format | marc |
| spelling | Chemotherapy and Immunotherapy in Urologic Oncology A Guide for the Advanced Practice Provider edited by Edouard J. Trabulsi, Costas D. Lallas, Anne E. Lizardi-Calvaresi 1st edition Cham Springer International Publishing 2021 1 Online-Ressource (XIV, 307 Seiten) Illustrationen txt rdacontent c rdamedia cr rdacarrier Introduction: Integration of APP into Urologic Oncology Practice -- Overview and Active Surveillance of Prostate Cancer -- Monitoring and Managing Men Following Initial Treatment of Prostate Cancer -- Radical Prostatectomy and Survivorship after Radical Prostatectomy -- Multimodal Treatment Plans in Prostate Cancer -- Radiotherapy for Prostate Cancer -- Androgen Deprivation Treatment -- Second Generation Androgen Targeted Agents -- Chemotherapy and prostate cancer -- Radiopharmaceuticals for Prostate Cancer -- Immunotherapy and Novel Agents on the Horizon for the Treatment of Prostate Cancer -- Bladder Cancer -- Intravesical Therapy for Non Muscle Invasive Urothelial Carcinoma -- Bladder Cancer: Muscle Invasive Disease -- Chemoradiation Bladder Preservation -- Metastatic Bladder Cancer and the Use of Cisplatin Chemotherapy -- Immunotherapy for Metastatic Urothelial Cancer -- Novel and experimental Strategies in the treatment of Metastatic Urothelial Carcinoma -- Upper Tract Urothelial Carcinoma -- Kidney Cancer and Its Treatment -- Targeted Therapies for Treatment of Metastatic Renal Cell Carcinoma -- Immune Therapies for Metastatic Kidney Cancer -- Novel Therapies for Renal Cell Carcinoma -- Testicular Cancer -- Penile Cancer This book is designed to familiarize clinical practitioners in systemic therapy options and medical management of urologic malignancies including prostate cancer, bladder and upper tract urothelial carcinoma, and renal cell carcinoma. Organized by organ system, the text highlights new therapies such as novel forms of androgen deprivation, cytotoxic chemotherapy, immune check point and immunomodulatory agents, and targeted therapies. Written by experts in the field, the book also reviews current chemotherapy and immunotherapy regimens for genitourinary malignancies and discusses indications, outcomes, and toxicities, as well as clinical trial concepts. Each of the book's chapters offers a bulleted box of clinical pearls on the particular role of the APP. Chemotherapy and Immunotherapy in Urologic Oncology: A Guide for the Advanced Practice Provider is a resource for urologists, uro-radiologists, medical clinicians and family practitioners alike, familiarizing its audiences with systemic therapy regimens for urologic malignancies, as well as their expected outcomes and side effects. Urology Oncology General practice (Medicine) Primary care (Medicine) Trabulsi, Edouard J. edt Lallas, Costas D. edt Lizardi-Calvaresi, Anne E. edt Erscheint auch als Druck-Ausgabe 9783030520205 Erscheint auch als Druck-Ausgabe 9783030520229 https://doi.org/10.1007/978-3-030-52021-2 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Chemotherapy and Immunotherapy in Urologic Oncology A Guide for the Advanced Practice Provider Urology Oncology General practice (Medicine) Primary care (Medicine) |
| title | Chemotherapy and Immunotherapy in Urologic Oncology A Guide for the Advanced Practice Provider |
| title_auth | Chemotherapy and Immunotherapy in Urologic Oncology A Guide for the Advanced Practice Provider |
| title_exact_search | Chemotherapy and Immunotherapy in Urologic Oncology A Guide for the Advanced Practice Provider |
| title_exact_search_txtP | Chemotherapy and Immunotherapy in Urologic Oncology A Guide for the Advanced Practice Provider |
| title_full | Chemotherapy and Immunotherapy in Urologic Oncology A Guide for the Advanced Practice Provider edited by Edouard J. Trabulsi, Costas D. Lallas, Anne E. Lizardi-Calvaresi |
| title_fullStr | Chemotherapy and Immunotherapy in Urologic Oncology A Guide for the Advanced Practice Provider edited by Edouard J. Trabulsi, Costas D. Lallas, Anne E. Lizardi-Calvaresi |
| title_full_unstemmed | Chemotherapy and Immunotherapy in Urologic Oncology A Guide for the Advanced Practice Provider edited by Edouard J. Trabulsi, Costas D. Lallas, Anne E. Lizardi-Calvaresi |
| title_short | Chemotherapy and Immunotherapy in Urologic Oncology |
| title_sort | chemotherapy and immunotherapy in urologic oncology a guide for the advanced practice provider |
| title_sub | A Guide for the Advanced Practice Provider |
| topic | Urology Oncology General practice (Medicine) Primary care (Medicine) |
| topic_facet | Urology Oncology General practice (Medicine) Primary care (Medicine) |
| url | https://doi.org/10.1007/978-3-030-52021-2 |
| work_keys_str_mv | AT trabulsiedouardj chemotherapyandimmunotherapyinurologiconcologyaguidefortheadvancedpracticeprovider AT lallascostasd chemotherapyandimmunotherapyinurologiconcologyaguidefortheadvancedpracticeprovider AT lizardicalvaresiannee chemotherapyandimmunotherapyinurologiconcologyaguidefortheadvancedpracticeprovider |